Arizona State Retirement System Has $142,000 Stake in Definitive Healthcare Corp. (NASDAQ:DH)

Arizona State Retirement System lifted its holdings in shares of Definitive Healthcare Corp. (NASDAQ:DH) by 13.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,253 shares of the company’s stock after purchasing an additional 1,701 shares during the quarter. Arizona State Retirement System’s holdings in Definitive Healthcare were worth $142,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Trust Point Inc. bought a new stake in Definitive Healthcare in the 4th quarter valued at $207,000. SG Americas Securities LLC lifted its holdings in shares of Definitive Healthcare by 30.0% in the fourth quarter. SG Americas Securities LLC now owns 18,802 shares of the company’s stock valued at $187,000 after purchasing an additional 4,342 shares in the last quarter. Baker Tilly Wealth Management LLC boosted its position in shares of Definitive Healthcare by 19.7% during the fourth quarter. Baker Tilly Wealth Management LLC now owns 59,956 shares of the company’s stock worth $596,000 after buying an additional 9,885 shares during the period. Vanguard Group Inc. grew its holdings in shares of Definitive Healthcare by 6.2% during the third quarter. Vanguard Group Inc. now owns 4,331,543 shares of the company’s stock worth $34,609,000 after buying an additional 254,726 shares in the last quarter. Finally, Wesbanco Bank Inc. acquired a new stake in Definitive Healthcare in the 3rd quarter valued at approximately $551,000. Institutional investors own 98.67% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on DH. Needham & Company LLC downgraded Definitive Healthcare from a “buy” rating to a “hold” rating in a research report on Wednesday, January 17th. Canaccord Genuity Group raised their target price on shares of Definitive Healthcare from $9.00 to $10.00 and gave the company a “hold” rating in a research report on Thursday, February 29th. Stifel Nicolaus cut their price target on shares of Definitive Healthcare from $12.00 to $11.00 and set a “buy” rating on the stock in a research report on Wednesday, January 17th. Canaccord Genuity Group cut Definitive Healthcare from a “buy” rating to a “hold” rating in a report on Friday, January 5th. Finally, Barclays upped their target price on Definitive Healthcare from $10.00 to $11.00 and gave the stock an “equal weight” rating in a report on Friday, March 1st. Seven analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $11.31.

Definitive Healthcare Trading Up 3.8 %

Definitive Healthcare stock opened at $7.33 on Tuesday. The stock has a 50-day simple moving average of $8.32 and a 200 day simple moving average of $8.31. The stock has a market capitalization of $863.39 million, a P/E ratio of -4.12, a PEG ratio of 6.15 and a beta of 1.39. The company has a debt-to-equity ratio of 0.20, a quick ratio of 2.31 and a current ratio of 2.31. Definitive Healthcare Corp. has a 52 week low of $5.53 and a 52 week high of $12.45.

Definitive Healthcare (NASDAQ:DH) last issued its earnings results on Wednesday, February 28th. The company reported ($0.01) EPS for the quarter, missing the consensus estimate of $0.01 by ($0.02). Definitive Healthcare had a positive return on equity of 0.43% and a negative net margin of 80.40%. The business had revenue of $65.93 million for the quarter, compared to the consensus estimate of $66.01 million. Analysts expect that Definitive Healthcare Corp. will post 0.11 earnings per share for the current year.

Definitive Healthcare Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.